Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Japan GLP-1 Receptor Agonist Market Analysis and Trends Japan remains a key regional player, distinguished by its strong healthcare infrastructure and universal insurance coverage
Interestingly, the medications that may be the most effective at achieving the desired outcome can be the ones that are more likely to cause adverse effects
Utilising our expertise and experience in medication adherence and patient compliance we acquire, monitor, analyse, guide and interpret data to deliver absolute clarity and bring confidence to sponsors, trialists, and ultimately, patients
Incretin-based therapies for type 2 diabetes: a focus on glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors
US$ 26.21
US$ 22.74
US$ 27.65
US$ 27.57
US$ 24.31
US$ 20.32
US$ 27.27
US$ 20.18
US$ 26.39
